Teijaro, J. R. et al. Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J. Immunol. 187, 5510–5514 (2011).
Google Scholar
Wu, T. et al. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J. Leukoc. Biol. 95, 215–224 (2014).
Google Scholar
Tchilian, E. & Holzer, B. Harnessing local immunity for an effective universal swine influenza vaccine. Viruses 9, 1–15 (2017).
Google Scholar
Lau, Y. F., Wright, A. R. & Subbarao, K. The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection. J. Virol. 86, 5089–5098 (2012).
Google Scholar
Song, K. et al. Genetic immunization in the lung induces potent local and systemic immune responses. Proc. Natl. Acad. Sci. USA 107, 22213–22218 (2010).
Google Scholar
McMichael, A. J., Gotch, F. M., Noble, G. R. & Beare, P. A. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309, 13–17 (1983).
Google Scholar
Wilkinson, T. M. et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18, 274–280 (2012).
Google Scholar
Sridhar, S. et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19, 1305–1312 (2013).
Google Scholar
Hayward, A. C. et al. Natural T cell-mediated protection against seasonal and pandemic influenza. results of the Flu Watch cohort study. Am. J. Respir. Crit. Care Med. 191, 1422–1431 (2015).
Google Scholar
Sridhar, S. Heterosubtypic T-cell immunity to influenza in humans: challenges for universal T-cell influenza vaccines. Front. Immunol. 7, 195 (2016).
Google Scholar
Coughlan, L. et al. Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults. EBioMedicine 29, 146–154 (2018).
Google Scholar
Sandbulte, M. R. et al. Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc. Natl. Acad. Sci. USA 108, 20748–20753 (2011).
Google Scholar
Kilbourne, E. D., Johansson, B. E. & Grajower, B. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proc. Natl. Acad. Sci. USA 87, 786–790 (1990).
Google Scholar
Kawai, A. et al. The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses. J. Virol. 95, e0118021 (2021).
Google Scholar
Wohlbold, T. J. et al. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. mBio 6, e02556 (2015).
Google Scholar
Deroo, T., Jou, W. M. & Fiers, W. Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 14, 561–569 (1996).
Google Scholar
McMahon, M. et al. Mucosal immunity against neuraminidase prevents influenza B virus transmission in guinea pigs. mBio 10 https://doi.org/10.1128/mBio.00560-19 (2019).
McMahon, M. et al. Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner. J. Virol. 97, e0105723 (2023).
Google Scholar
Strohmeier, S. et al. A novel recombinant influenza virus neuraminidase vaccine candidate stabilized by a measles virus phosphoprotein tetramerization domain provides robust protection from virus challenge in the mouse model. mBio 12, e0224121 (2021).
Google Scholar
Vatzia, E. et al. Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs. NPJ Vaccines 8, 19 (2023).
Google Scholar
Judge, E. P. et al. Anatomy and bronchoscopy of the porcine lung. A model for translational respiratory medicine. Am. J. Respir. Cell Mol. Biol. 51, 334–343 (2014).
Google Scholar
Rajao, D. S. & Vincent, A. L. Swine as a model for influenza A virus infection and immunity. ILAR J. 56, 44–52 (2015).
Google Scholar
Holzer, B., Martini, V., Edmans, M. & Tchilian, E. T and B cell immune responses to influenza viruses in pigs. Front. Immunol. 10, 98 (2019).
Google Scholar
Pabst, R. The pig as a model for immunology research. Cell Tissue Res. 380, 287–304 (2020).
Google Scholar
Walters, E. M., Wells, K. D., Bryda, E. C., Schommer, S. & Prather, R. S. Swine models, genomic tools and services to enhance our understanding of human health and diseases. Lab Animal 46, 167–172 (2017).
Google Scholar
Anderson, T. K. et al. Swine influenza A viruses and the tangled relationship with humans. Cold Spring Harb. Perspect. Med. https://doi.org/10.1101/cshperspect.a038737 (2020).
Schwaiger, T. et al. Experimental H1N1pdm09 infection in pigs mimics human seasonal influenza infections. PLoS ONE 14, e0222943 (2019).
Google Scholar
Halbur, P. G. et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet. Pathol. 32, 648–660 (1995).
Google Scholar
Gauger, P. C. et al. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Vet. Pathol. 49, 900–912 (2012).
Google Scholar
Martini, V. et al. Distribution of droplets and immune responses after aerosol and intra-nasal delivery of influenza virus to the respiratory tract of pigs. Front. Immunol. 11, 594470 (2020).
Google Scholar
Morgan, S. B. et al. Aerosol delivery of a candidate universal influenza vaccine reduces viral load in pigs challenged with pandemic H1N1 virus. J. Immunol. 196, 5014–5023 (2016).
Google Scholar
Vatzia, E. et al. Respiratory and intramuscular immunization with ChAdOx2-NPM1-NA induces distinct immune responses in H1N1pdm09 pre-exposed pigs. Front. Immunol. 12, 763912 (2021).
Google Scholar
Nachbagauer, R. et al. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial. Nat. Med. 27, 106–114 (2021).
Google Scholar
Kanekiyo, M. et al. Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nat. Immunol. 20, 362–372 (2019).
Google Scholar
Nachbagauer, R. & Palese, P. Is a universal influenza virus vaccine possible? Annu. Rev. Med. 71, 315–327 (2020).
Google Scholar
Wei, C.-J. et al. Next-generation influenza vaccines: opportunities and challenges. Nat. Rev. Drug Discov. 19, 239–252 (2020).
Google Scholar
Zhu, F. et al. Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir. Med. 11, 1075–1088 (2023).
Google Scholar
Wang, S. Y., Liu, W. Q., Li, Y. Q., Li, J. X. & Zhu, F. C. A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov. Expert Rev. Vaccines 22, 704–713 (2023).
Google Scholar
Huang, T. et al. Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study. Lancet Respir. Med. 11, 698–708 (2023).
Google Scholar
Cape, S. et al. Safety and immunogenicity of dry powder measles vaccine administered by inhalation: a randomized controlled Phase I clinical trial. Vaccine 32, 6791–6797 (2014).
Google Scholar
Low, N. et al. A randomized, controlled trial of an aerosolized vaccine against measles. N. Engl. J. Med. 372, 1519–1529 (2015).
Google Scholar
Jegaskanda, S. et al. Induction of H7N9-cross-reactive antibody-dependent cellular cytotoxicity antibodies by human seasonal influenza A viruses that are directed toward the nucleoprotein. J. Infect. Dis. 215, 818–823 (2016).
Google Scholar
Mohn, K. et al. Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. J. Infect. Dis. 211 https://doi.org/10.1093/infdis/jiu654 (2014).
Sathaliyawala, T. et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 38, 187–197 (2013).
Google Scholar
Mohn, K. G. et al. Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. J. Infect. Dis. 211, 1541–1549 (2015).
Google Scholar
Uddbäck, I. et al. Long-term maintenance of lung resident memory T cells is mediated by persistent antigen. Mucosal Immunol. 14, 92–99 (2021).
Google Scholar
Everett, H. E. et al. Vaccines that reduce viral shedding do not prevent transmission of H1N1 pandemic 2009 swine influenza A virus infection to unvaccinated pigs. J. Virol. 95 https://doi.org/10.1128/jvi.01787-20 (2021).
Zheng, M., Luo, J. & Chen, Z. Development of universal influenza vaccines based on influenza virus M and NP genes. Infection 42, 251–262 (2014).
Google Scholar
Chen, Q. et al. Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus. Virus Genes 38, 30–38 (2009).
Google Scholar
Okuda, K. et al. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine 19, 3681–3691 (2001).
Google Scholar
Townsend, A. R. et al. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44, 959–968 (1986).
Google Scholar
Yewdell, J. W., Bennink, J. R., Smith, G. L. & Moss, B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 82, 1785–1789 (1985).
Google Scholar
Misplon, J. A., Lo, C. Y., Crabbs, T. A., Price, G. E. & Epstein, S. L. Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination. J. Virol. 97, e0067423 (2023).
Google Scholar
Lo, C. Y. et al. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies. Vaccine 26, 2062–2072 (2008).
Google Scholar
Guo, L. et al. Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein. Arch. Virol. 155, 1765–1775 (2010).
Google Scholar
Ye, Z. P., Baylor, N. W. & Wagner, R. R. Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J. Virol. 63, 3586–3594 (1989).
Google Scholar
Adler, S., Reay, P., Roy, P. & Klenk, H. D. Induction of T cell response by bluetongue virus core-like particles expressing a T cell epitope of the M1 protein of influenza A virus. Med. Microbiol. Immunol. 187, 91–96 (1998).
Google Scholar
Plotnicky, H. et al. The immunodominant influenza matrix T cell epitope recognized in human induces influenza protection in HLA-A2/K(b) transgenic mice. Virology 309, 320–329 (2003).
Google Scholar
Lee, L. Y. et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Investig. 118, 3478–3490 (2008).
Google Scholar
Schmidt, A. et al. Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model. Front. Immunol. 14, 1181716 (2023).
Google Scholar
Holzer, B. et al. Comparison of heterosubtypic protection in ferrets and pigs induced by a single-cycle influenza vaccine. J. Immunol. 200, 4068–4077 (2018).
Google Scholar
Lapuente, D. et al. IL-1β as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses. Mucosal Immunol. 11, 1265–1278 (2018).
Google Scholar
Heinen, P. P., Rijsewijk, F. A., de Boer-Luijtze, E. A. & Bianchi, A. T. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J. Gen. Virol. 83, 1851–1859 (2002).
Google Scholar
Hillaire, M. L., Rimmelzwaan, G. F. & Kreijtz, J. H. Clearance of influenza virus infections by T cells: risk of collateral damage? Curr. Opin. Virol. 3, 430–437 (2013).
Google Scholar
Duan, S. & Thomas, P. G. Balancing immune protection and immune pathology by CD8(+) T-cell responses to influenza infection. Front. Immunol. 7, 25 (2016).
Google Scholar
Wells, M. A., Albrecht, P. & Ennis, F. A. Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J. Immunol. 126, 1036–1041 (1981).
Google Scholar
Morris, S. J., Sebastian, S., Spencer, A. J. & Gilbert, S. C. Simian adenoviruses as vaccine vectors. Future Virol. 11, 649–659 (2016).
Google Scholar
